Krishna Institute of Medical Sciences Q1 Results FY26: Q1 PAT Narrows 9.24% to ₹78.60 Crore; Revenue Jumps 26.61% YoY

Krishna Institute of Medical Sciences Q1 Results FY26: Krishna Institute of Medical Sciences posted its Q1 results on 6th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹78.60 crores against revenue of ₹871.60 crores. During Q1 FY26, the profit decrease of the company was recorded at 9.24% YoY, and the revenue increase for the same period was 26.61%. 

Krishna Institute of Medical Sciences Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

Krishna Institute of Medical Sciences Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Krishna Institute of Medical Sciences Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Krishna Institute of Medical Sciences clocked Q1 FY26 consolidated revenue of ₹871.60 crores vs ₹688.40 crores. 
• On the profit front, Krishna Institute of Medical Sciences earned a consolidated PAT of ₹78.60 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹86.60 crore. 
• Consolidated PAT fell for the first quarter of FY26, was 9.24% YoY, and revenue rose 26.61% YoY. 
• As per the standalone figures, the quarterly PAT of Krishna Institute of Medical Sciences has decreased by 3.13% and revenue has increased by 14.05% YoY.

Krishna Institute of Medical Sciences Share Price Performance

On the opening bell of 6th August 2025, the shares of Krishna Institute of Medical Sciences opened at ₹741.00 per share. However, the initial gains are sustained as of now, and Krishna Institute of Medical Sciences shares are trading at ₹745.00 per share, higher than their opening price. 

Considering the long-term performance, Krishna Institute of Medical Sciences shares have yielded close to 74.02% returns in the past 1 year, and 5-year returns stand at 265.82%. Over the maximum timeframe, the Krishna Institute of Medical Sciences shares provided 265.82% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Krishna Institute of Medical Sciences shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : INDIGO Q1 Results FY26: Q1 PAT Falls 20.25% to ₹2,176.30 Crore; Revenue Surged 4.73% YoY

Recent Articles

Best Penny Stocks for Long Term in India | Penny Stocks in 2025

Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY

Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY

Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to ₹171.00 Crore; Revenue Up 44.23% YoY